[Federal Register Volume 80, Number 77 (Wednesday, April 22, 2015)]
[Notices]
[Page 22553]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-09350]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Manufacturer of Controlled Substances Registration: Cedarburg 
Pharmaceuticals, Inc.

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Cedarburg Pharmaceuticals, Inc. applied to be registered as a 
manufacturer of certain basic classes of controlled substances. The DEA 
grants Cedarburg Pharmaceuticals, Inc. registration as a manufacturer 
of the controlled substances.

SUPPLEMENTARY INFORMATION: By notice dated June 10, 2014, and published 
in the Federal Register on June 17, 2014, 79 FR 34553, Cedarburg 
Pharmaceuticals, Inc., 870 Badger Circle, Grafton, Wisconsin 53024 
applied to be registered as a manufacturer of certain basic classes of 
controlled substances. No comments or objections were submitted to this 
notice.
    The Drug Enforcement Administration (DEA) has considered the 
factors in 21 U.S.C. 823(a) and determined that the registration of 
Cedarburg Pharmaceuticals, Inc. to manufacture the basic classes of 
controlled substances is consistent with the public interest and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA investigated the company's 
maintenance of effective controls against diversion by inspecting and 
testing the company's physical security systems, verifying the 
company's compliance with state and local laws, and reviewing the 
company's background and history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above-named company is granted registration as a bulk 
manufacturer of the basic classes of controlled substances listed:

------------------------------------------------------------------------
                     Controlled substance                       Schedule
------------------------------------------------------------------------
4-Anilino-N-phenethyl-4-piperidine (ANPP) (8333).............         II
Remifentanil (9739)..........................................         II
Fentanyl (9801)..............................................         II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for distribution to its customers.
    Regarding the drug code (8333), the company plans to manufacture 
this listed controlled substance for commercial sale.

    Dated: April 14, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-09350 Filed 4-21-15; 8:45 am]
BILLING CODE P